Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843330 · ClinicalTrials.gov registry record
Accuracy of Lactate Meter in GSDIa
A clinical trial of Glycogen Storage Disease Type Ia, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06843330: Recruiting study of Glycogen Storage Disease Type Ia, sponsored by Connecticut Children's Medical Center.
NCT06843330 is a study of Glycogen Storage Disease Type Ia that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 10 participants, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843330, a study of Glycogen Storage Disease Type Ia, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.
Primary Outcome
Lactate level via point of care finger-stick and lab draw
Conditions Studied
Interventions
- DEVICE blood glucose meter; blood lactate meter
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-04-14 |
| Est. Completion | 2027-12-10 |
What NCT06843330 shows while recruiting
NCT06843330 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Glycogen Storage Disease Type Ia appearing as the primary indexed condition, and to 1 intervention - of which blood glucose meter; blood lactate meter is the first listed.
NCT06843330 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06843330 about?
NCT06843330 is a clinical study titled "Accuracy of Lactate Meter in GSDIa". The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurat...
What is the current status of trial NCT06843330?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-04-14. Estimated completion is 2027-12-10.
What conditions does trial NCT06843330 study?
This clinical trial studies the following conditions: Glycogen Storage Disease Type Ia.
What interventions are being tested in trial NCT06843330?
The interventions under investigation include: blood glucose meter; blood lactate meter (DEVICE).
Who is sponsoring clinical trial NCT06843330?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843330 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease Type Ia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
RECRUITING · Phase 1
-
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
RECRUITING
-
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
RECRUITING
-
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
COMPLETED · Phase 3
-
Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI